ReviewInternational journal of environmental research and public health2021
A Rapid Review of COVID-19 Vaccine Prioritization in the U.S.: Alignment between Federal Guidance and State Practice.
Review in International journal of environmental research and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 1 synthesis or guideline pooled it.
- COVID-19 in the homeless population: a scoping review and meta-analysis examining differences in prevalence, presentation, vaccine hesitancy and government response in the first year of the pandemic.BMC infectious diseases · 2023Pooled it
- Qualitative exploration of COVID-19 vaccine uptake among healthcare workers in Sierra Leone: do the 'trusted messengers' trust the vaccine?BMJ public health · 2026Article
- A descriptive investigation of the impact of statewide distribution policies and consumer vulnerabilities on COVID-19 vaccination in the united States.Health care management science · 2025Article
- U.S. trust in physicians as key public health messengers during the H5N1 avian influenza outbreak.Scientific reports · 2025Article
- Rural-Urban Disparities in COVID-19 Vaccine Uptake and Associated Mortality and Cardiovascular Disease Outcomes in the United States.Vaccines · 2025Review
- Modeling the impact of early vaccination in an influenza pandemic in the United States.NPJ vaccines · 2025Article
- Wait-times benchmarks for risk-based prioritization in transcatheter aortic valve implantation: a simulation study.European heart journal. Quality of care & clinical outcomes · 2025Article
- The Impact of State COVID-19 Responses on People With Intellectual and Developmental Disabilities.Inclusion (Washington, D.C.) · 2025Article
- COVID-19 vaccination receipt and intention to vaccinate among adults with disabilities and functional limitations, United States.Annals of medicine · 2024Article
- A Letter to the Editor Regarding 'Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Older Adults: Systematic Literature Review and Meta-analysis Using the GRADE Framework'.Infectious diseases and therapy · 2024Article
- Biomedical Big Data Technologies, Applications, and Challenges for Precision Medicine: A Review.Global challenges (Hoboken, NJ) · 2024Review
- COVID-19 infection and severe clinical outcomes in patients with kidney disease by vaccination status: a nationwide cohort study in Korea.Epidemiology and health · 2024Article
- All hands on deck during the COVID-19 pandemic. Maintaining face-to-face medical education and clinical placements.PloS one · 2024Article
- Article
- COVID-19 Vaccination Hesitancy in Autoimmune Disease Patients: Policy Action and Ethical Considerations.Vaccines · 2023Review
- Article
- COVID-19 Vaccination Rates of People Who Use Drugs - Chengdu City, Sichuan Province, China, November 2021 - February 2022.China CDC weekly · 2022Article
- COVID-19 Vaccination Intentions amongst Healthcare Workers: A Scoping Review.International journal of environmental research and public health · 2022Article
- Which countries need COVID-19 vaccines the most? Development of a prioritisation tool.BMC public health · 2022Article
- COVID-19 vaccine behaviors and intentions among a national sample of United States adults ages 18-45.Preventive medicine · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPopulation groups to be prioritized for COVID-19 vaccinations in the U.S. have been determined at the Federal level, but there is variation in how States have implemented guidance. This review examines how the position of population groups in vaccine priority lists varies between Federal guidance and State practice.
methodsAn online search of State vaccination prioritization plans was conducted. Data were extracted on each population group included and their relative position. A standardized ranking method was applied to provide a directional measure of variability in prioritization between State and Federal guidance, for each population group.
resultsHealthcare workers and those in long-term care facilities were largely prioritized in line with Federal guidance. Aside from early education staff, essential workers were often excluded at State level. Almost all States included the 65-74 year age group and most assigned them to a higher position than recommended in Federal guidance. Those with underlying medical conditions were similarly highly prioritized, although there was more variability across States. Some socially vulnerable groups (not included in Federal guidance) were highly prioritized by many States.
conclusionsThe prioritization of groups for COVID-19 vaccination has been highly variable despite clear Federal guidance. Future guidance must be relevant to local needs, values, and constraints, to minimize any unwarranted heterogeneity in vaccine access across populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.